Background Approximately 90% of genital warts are caused by human papillomavirus (HPV)
types 6 and 11. In the United States, HPV vaccination has been recommended for girls and …

Background A quadrivalent vaccine that prevents genital warts (GWs) has been
recommended by the Advisory Committee on Immunization Practices for women since 2007 …

Objectives. To detect decreases in anogenital warts (AGW) among sex and age groups
likely to be affected by human papillomavirus vaccination. Methods. We estimated annual …

Abstract Background Anogenital warts (AGWs) are a common, highly infectious disease
caused by the human papillomavirus (HPV), whose high recurrence rates contribute to direct …

Background Information on genital wart incidence in adolescents and young adults before
human papillomavirus (HPV) vaccination is important for understanding the impact of the …

Objectives. We estimated anogenital wart prevalence from 2003 to 2010 by gender and age
group in a large US cohort with private insurance to detect potential decreases among …

Introduction Evidence of human papillomavirus (HPV) vaccine impact on anogenital warts
(AGWs) by race or urbanicity in the US is lacking. We evaluated HPV vaccine impact in …

Background: Anogenital warts are a common initial presentation to the Canberra Sexual
Health Centre. It is anticipated that the introduction of human papillomavirus vaccination will …

Background Human papillomavirus (HPV) vaccination remains underused in the United
States, and few population-level studies on effectiveness exist. Methods We examined …

Background: Genital warts are caused by human papillomavirus (HPV); over 90% are due to
HPV types 6 and 11. We determined the percentage of persons who reported having been …